…Fears Skin Cancer, Glaucoma & Cataracts For Users
The Food and Drugs Authority (FDA), has cautioned the general public against the use of creams, ointments, lotions and other topical preparations containing steroid for skin lightening, cosmetics and other non-medical purposes, suggesting one could be at risk of contracting cancer.
It warned that the over-exposure to steroid such as Betamethasone, Clobetasol, Fluocinonide, Acetonide, and Hydrocortisone, pose a serious risk to the skin, eyes and other parts of the human body.
A statement signed and released on Saturday by the Chief Executive Officer (CEO) of FDA, said that “it must be noted that such preparations including Betnovate, Dermovate, Tenovate, Lemonvate, Epiderm, Dexacort have been registered by the FDA as Prescription-Only-Medicines (POMs) and as such should be sold or bought only on prescription of a qualified medical doctor”.
The FDA boss, Hudu Mogtari, mentioned that frequent, indiscriminate and prolonged use of such corticorsteriod-containing preparations are associated with thinning of the skin, leading to difficulty in holding the skin during surgery, making the affected skin more prone to damage like bruising, development or worsening of acne and permanent stretch marks.
The statement also mentioned Hyperpigmentation, Glaucoma and even Cataracts, upon prolonged application to the eyelids, inhibition of the skin’s ability to fight off bacterial or fungal infections leading to their absorption into the blood stream.
He, therefore, warned the public to desist from selling or buying such products from cosmetic shops, markets, hawkers, drug peddlers and from Pharmacies without the required prescription from qualified medical personnel.
Mr. Mogtari, charged “any person or company found selling these POM preparations from cosmetics shops, markets, lorry stations and or by hawking or peddling; or from Pharmacies without prescription will face stringent regulatory sanctions”.
The FDA further encouraged the public to provide information on persons in any activities that are likely to endanger public health and safety with respect to FDA’s mandate through 0244337235, 0544863418, Toll Free line 0800-151-000 (Free only on Vodafone and Airtel Networks) or its Short Code: 4015 (Free on all Networks excluding GLO).